FDA Estimates Dollar Costs For Adverse Event Labeling But Doubts Persist
This article was originally published in The Tan Sheet
Executive Summary
FDA's estimate of nearly $44 million for the dietary supplement industry to revise labels to comply with the adverse event reporting law may understate the actual burden by leaving out some key costs
You may also be interested in...
Final AER Guidance Requires Full Address, Recommends Prefatory Language
In its final adverse event reports labeling guidance documents released Sept. 1, FDA does not budge on defining "domestic address" as a full mailing address, or on recommending labels include statements directing consumers how to submit AERs
Final AER Guidance Requires Full Address, Recommends Prefatory Language
In its final adverse event reports labeling guidance documents released Sept. 1, FDA does not budge on defining "domestic address" as a full mailing address, or on recommending labels include statements directing consumers how to submit AERs
Final AER Guidance Requires Full Address, Recommends Prefatory Language
In its final adverse event reports labeling guidance documents released Sept. 1, FDA does not budge on defining "domestic address" as a full mailing address, or on recommending labels include statements directing consumers how to submit AERs